View Article

Abstract

The present research work was undertaken to develop and validate a simple, precise, accurate, and reliable Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method for the estimation of selected marker compounds in Sitopaladi Churna and to compare the quality of different commercially available brands of the formulation. Herbal and Ayurvedic medicines are extensively used worldwide because of their therapeutic effectiveness, natural origin, and minimal side effects. Objective:The present study was aimed at developing and validating a simple, precise, accurate, and robust Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method for the estimation of a selected marker compound in Sitopaladi Churna and to compare the quality of different commercially available brands based on the content of the marker compound.Method:An RP-HPLC method was developed using a C18 column with an optimized mobile phase composition, flow rate, and detection wavelength suitable for the selected marker compound. The method was validated according to the International Council for Harmonisation guidelines for parameters including specificity, linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), and robustness. Samples of different commercial brands of Sitopaladi Churna were procured from the market and prepared according to standard extraction procedures. Quantitative analysis of the marker compound was performed using the validated RP-HPLC method, and the results were statistically compared.Results:The developed RP-HPLC method showed good chromatographic separation with a well-resolved peak of the marker compound and satisfactory system suitability parameters. The method exhibited excellent linearity over the selected concentration range (R² > 0.999), with acceptable precision (%RSD < 2%) and accuracy (recovery within 98–102%). The LOD and LOQ values demonstrated adequate sensitivity, while robustness studies confirmed the reliability of the method under small experimental variations. Analysis of different commercial brands revealed significant variations in the content of the marker compound, indicating differences in raw material quality, manufacturing practices, and standardization procedures among the brands.Conclusion:The validated RP-HPLC method was found to be simple, sensitive, accurate, and suitable for routine quality control analysis of Sitopaladi Churna. Comparative evaluation of commercial brands highlighted variability in marker compound content, emphasizing the need for stringent quality control and standardization to ensure the safety, efficacy, and consistency of Ayurvedic formulations.

Keywords

RP-HPLC,Sitophaladi churn marketed brands ,Extraction, Analytical Method Development, Method Validation,Simultaneous Estimation, Stability-Indicating Method, ICH Guidelines, , Chromatographic Separation , Quality Control Analysis, Forced Degradation Studies

Introduction

× Popup Image

Sitopaladi Churna is a widely used Ayurvedic polyherbal formulation described in classical Ayurvedic texts for the management of respiratory disorders such as cough, cold, bronchitis, and asthma. It consists of ingredients including sugar candy (Mishri), bamboo manna (Vanshlochan), long pepper (Pippali), cardamom (Ela), and cinnamon (Tvak). The therapeutic efficacy of Sitopaladi Churna depends on the quality, purity, and consistency of its constituent ingredients.Standardization of herbal formulations is essential to ensure their safety, efficacy, and batch-to-batch consistency. High-Performance Liquid Chromatography (HPLC) has emerged as a reliable analytical technique for the qualitative and quantitative evaluation of herbal medicines. Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) is particularly useful for the estimation of marker compounds in complex herbal formulations due to its high sensitivity, accuracy, and reproducibility.The present study focuses on the development and validation of an RP-HPLC method for the estimation of a selected marker compound in Sitopaladi Churna. Furthermore, the validated method was applied to compare the quality of different commercially available brands based on the content of the marker compound, thereby assessing their degree of standardization and quality compliance.

MATERIALS AND METHODS

Different commercial brands of Sitopaladi Churna were procured from local pharmacies and authenticated based on label information. The reference standard of the selected marker compound was obtained from a certified supplier. HPLC-grade methanol, acetonitrile, water, and analytical-grade reagents were used throughout the study. RP-HPLC analysis was performed using a High-Performance Liquid Chromatography system equipped with a UV-Visible detector, autosampler, and data acquisition software. Separation was achieved using a C18 reverse-phase analytical column.

PREPARATION OF METHOD

An RP-HPLC method was developed for the estimation of the marker compound in Sitopaladi Churna. Various chromatographic conditions were optimized to obtain good peak resolution, symmetry, and reproducibility. A C18 reverse-phase column was selected as the stationary phase due to its suitability for the separation of phytoconstituents.Different combinations of aqueous and organic solvents were evaluated as the mobile phase. The optimized mobile phase was filtered through a 0.45 μm membrane filter and degassed before use. The flow rate, injection volume, and detection wavelength were adjusted to achieve satisfactory chromatographic performance.A standard solution of the marker compound was prepared and injected into the HPLC system to determine its retention time and peak characteristics. Sample solutions prepared from different brands of Sitopaladi Churna were analyzed under the optimized chromatographic conditions. The developed method was subsequently validated according to ICH guidelines for specificity, linearity, accuracy, precision, robustness, limit of detection (LOD), and limit of quantification (LOQ).The validated RP-HPLC method was then employed for the quantitative estimation of the marker compound and comparative quality assessment of different commercial brands of Sitopaladi Churna. Mobile phase was selected on the basis of good resolution, peak purity, peak symmetry, theoretical plates etc. Different solvents in various ratios were used to obtain a peak of Piperine .Based on literature survey and solubility of drugs acetonitrile and formic acid was tried in the various proportions to develop the method. This mobile phase was suitable as it shows peak tailing in chromatogram. Then acetonitrile and double distilled water was tried and found to be suitable mobile phase.

                                           

 

Table no 1 RPHPLC Conditions

 

 

 

 

UV Analysis of Piperine in Commercial Brands

The UV spectrophotometric analysis of Piperine present in different commercial brands of Sitopaladi Churn was carried out to confirm the presence of the marker compound and to compare the spectral characteristics across formulations

 

Table no 2 Various Extraction

 

Sr. No.

 

Name of commercial brand

 

 

Manufacturer

 

Formulation code

1

Dabur Sitopaladi Churna

Dabur India Ltd.

S1

2

Baidyanath Sitopaladi Churna

Shree Baidyanath Ayurved Bhawan Pvt. Ltd.

S2

3

Himalaya Sitopaladi Churna

The Himalaya Drug Company

S3

 

Procedure

Accurately weighed 500 mg of Sitopaladi Churn from each commercial brand (e.g., Dabur, Baidyanath, Zandu, Himalaya, Charak). Each sample was extracted separately with methanol (50 mL) in a conical flask. The mixtures were sonicated for 30 minutes to ensure complete extraction of phytoconstituents. The extracts were filtered using Whatman filter paper and further filtered through a 0.45 µm syringe filter. Suitable dilutions were prepared from each filtrate to obtain measurable absorbance. Each sample solution was scanned in the range of 200–400 nm using UV-Visible spectrophotometer against methanol as blank. The spectra obtained were compared with the standard Piperine spectrum.

Observation

 All three commercial brands showed absorption peaks in the UV region similar to that of standard Piperine. A characteristic absorption maximum was observed at approximately 343 nm, confirming the presence of Piperine. Slight variations in absorbance intensity were observed among different brands,

Method development by RP-HPLC and optimization-

Preparation of Mobile phase

Mobile phase was prepared by using double distilled water of pH 3-4.5 adjusted with (0.1%v/v) OPA and acetonitrile. The double distilled water was taken which is adjusted to pH3-4.5with Ortho-Phosphoric Acid and was filtered through 0.45 µm Nylon 6,6 membrane filter and was degassed by ultra sonicator. Acetonitrile was filtered through 0.45 µm Nylon 6,6 membrane filter and was degassed by ultrasonicator.

Preparation of stock solution

The stock solution of Piperine was prepared for RP-HPLC analysis to construct the calibration curve and for quantitative estimation in different commercial brands of Sitopaladi Churn.

Procedure

Accurately weighed 10 mg of Piperine standard using an analytical balance. Transferred the weighed standard into a 10 mL volumetric flask. Added approximately 5 mL of methanol and sonicated for 5–10 minutes to ensure complete dissolution of the compound. The volume was then made up to 10 mL with methanol to obtain a stock solution of 1000 µg/mL (1 mg/mL). The stock solution was stored in a refrigerator (2–8°C) when not in use to maintain stability

Preparation of sample solution of marketed formulation

The sample solution of Sitopaladi Churn from different commercial brands was prepared for quantitative analysis of Piperine by RP-HPLC.

Procedure

Accurately weigh 500 mg of Sitopaladi Churn from a selected commercial brand. Transfer the powdered sample into a 50 mL volumetric flask. Add approximately 25 mL of methanol to the flask. Sonicate the mixture for 30 minutes to extract Piperine completely. Allow the solution to cool (if any heat is generated during sonication) and dilute to the mark with methanol. Mix well to obtain a homogeneous solution. Filter the solution through a 0.45 µm syringe filter to remove insoluble particles before HPLC injection. Transfer the filtered solution to an HPLC vial for analysis.

Dilution for HPLC Analysis

If required, prepare a suitable dilution of the sample solution to match the concentration range of the calibration curve. Example: Take 1 mL of filtered sample solution and dilute to 10 mL with methanol to obtain a working sample solution.

Optimization of Developed method-

Optimization in HPLC is the process of finding a set of conditions that adequately separate and enable the quantification of analyte from the endogenous material with acceptable accuracy, precision, sensitivity, specificity, cost, ease and speed. Various trials were carried out by using different composition of mobile phase. Initially the study was started with 100 % acetonitrile followed by use of various other compositions. It was observed that peak of Piperine was too broad to get satisfactory retention time of compound. The concentration of organic phase was decreased. The optimum mobile phase composition was found to be containing acetonitrile: double distilled water pH adjusted with ortho-phosphoric acid (50: 50) at flow rate 1ml/ min. This optimum condition was selected so as to shift the retention time of drug at sufficient length of time. The run time is kept as 20 minute.

Validation of method-

Validation of Analytical Method may be defined as the process by which it is established, by laboratories studies, that the performance characteristics of the method meet the requirements for the intended analytical application. Typical validation parameters to be considered are as follows:

Linearity:Linearity of Piperine(S1 S2 and S3) was performed using standard solution in the range of 1-7 µg/ml of each drugs.

Acceptance criteria: Correlation coefficient (R2) should be not less than 0.999.

Range:

For range, data shall be considered from linearity and accuracy.

Acceptance criteria- Correlation coefficient (R2) should be not less than 0.999 and individual % recovery of at each level should be between 98 % - 102 %.

System Suitability-

System suitability testing is essential for the assurance of the quality performance of the chromatographic system. The system suitability parameters with respect to theoretical plates, capacity factor, resolution factor, tailing factor were calculated. In system suitability was evaluated by analyzing different concentration of 1-7 µg/ml of Piperine(S1 S2 and S3) Limit of detection (LOD) and Limit of Quantitation (LOQ)-The limit of detection (LOD) and limit of quantitation (LOQ) were determined by calculating the signal to noise (S/N) ratio of the LOD preparation and LOQ preparation. The Limit of detection (LOD) and Limit of Quantitation (LOQ) were evaluated from calibration curve of linearity data.

Acceptance criteria- A lower LOD and LOQ value indicates high sensitivity of the method.

Accuracy and Recovery-

To evaluate the recovery at each level, working standards of the drugs were added at three different concentrations (levels) 80 %, 100 % and 120 %, to the known amount of sample which was kept constant. The measurements were done in triplicates.

Acceptance criteria: Individual % recovery of Piperine(S1 S2 and S3)  at each level should be between 98 % - 102% and % RSD should not be more than 2.0 at each level.

Precision-

Precision of the method was verified by repeatability and intermediate precision studies. Repeatability studies were performed by analyses of 1 µg/ml of the sample for five times on the same day. Intraday and Interday precision of the method was checked by repeating the studies on within same day and at different days.

Acceptance criteria: % RSD should not be more than 2.0.

Ruggedness-

Ruggedness of the method was verified by analyzing samples of the same batch used for method   precision as per proposed method by different analyst. The SD and % RSD of Piperine(S1 S2 and S3) was determined.

Acceptance criteria: % RSD should not be more than 2.0

Robustness-

To determine the robustness of the method, experimental conditions were purposely altered. Two parameters selected were flow rate and mobile phase ratio. The flow rate of mobile phase was 1 ml/min. This was changed to 0.8 ml/min and 1.2 ml/min and effect was studied. The mobile phase ratio was 50:50. This was changed to 55:45 and 53:47 and effect was studied. When the effect of altering one set of conditions was tested, the other conditions were held constant at the optimum values.

Forced Degradation Study-

Stress studies were carried as per ICH guideline. Degradation studies were performed with standard & bulk drug. The following conditions were applied for forced degradation.

Acidic Condition-

The degradation study was carried out by taking 1mg of each Piperine(S1 S2 and S3) in small RBF & 0.5 ml acetonitrile was added to dissolve all drugs. Then add 1 ml of 0.1 N HCl to it. This solution was refluxed at 80 0 C for 1 hours. Then solution were withdrawn from RBF in 10 ml volumetric flask & kept at room temperature. It is then neutralized with 0.1 N NaOH. This solution was filtered by membrane filtre.1 ml of degraded sample was diluted with mobile phase to 10 ml in volumetric flask.

Basic condition-

The degradation study was carried out by taking 1mg of each Piperine(S1 S2 and S3) in small RBF and add 1 ml/ mg of 0.1 N NaOH in RBF . This solution was refluxed at 80 0 C for 1 hours. Then solution were withdrawn from RBF in 10 ml volumetric flask and kept at room temperature. It is then neutralized with 0.1 N HCl. This solution filtered by membrane filter. 1 ml of degraded sample was diluted with mobile phase to 10 ml in volumetric flask.

Neutral Condition

The degradation study was carried out by taking 1 mg of each Piperine(S1 S2 and S3) in 10 ml volumetric flask and adds 1ml/ mg double distilled water to it. This solution was sonicated for 5 min in order to dissolve the drug and kept at room temperature for 1 hour. This solution was filtered by membrane filter. 1 ml of degraded sample was diluted with mobile phase to 10 ml in volumetric flask.

Oxidative Condition-

1mg of each Piperine(S1 S2 and S3) was taken in RBF and add 6 % v/v H 2O2. Then solution was refluxed at 80 0 C for 1 hours. Then solution was withdrawn from RBF in 10 ml volumetric flask allowed to room temperature. 1 ml of degraded sample was diluted with mobile phase to 10 ml in volumetric flask.

Thermal Degradation-

For thermal stress study Piperine(S1 S2 and S3) solid drugs were kept in dry oven at 1050 C for 24 Hours. The 1 µg/ml solution was prepared with mobile phase and analyzed.

Photolytic Degradation-

Forced degradation was carried out under stress conditions of photolysis (UV light -254 nm).The solid powder of all drugs was kept in petri plate for 5 hours. The degraded sample was dissolved in mobile phase and then injected.

RESULTS AND DISCUSSION-

Selection of various brands sitophaladi churn

Select three brands for the comparative study according to their celling situation. The brands contains various ingredients but the main marker constituent is piperine

 

Table no.3 Name of commercial brand

 

Sr. No.

 

Name of commercial brand

 

 

Manufacturer

 

Formulation code

1

Dabur Sitopaladi Churna

Dabur India Ltd.

S1

2

Baidyanath Sitopaladi Churna

Shree Baidyanath Ayurved Bhawan Pvt. Ltd.

S2

3

Himalaya Sitopaladi Churna

The Himalaya Drug Company

S3

 

Purchase Samples

All sample was purchased from Ahilya medical and retail shop from Pathri within expiry. 

 

Table no.4 Purchase Samples information

 

Sr. No.

 

Name of commercial brand

 

 

Batch no

 

Expiry date

1

Dabur Sitopaladi Churna

DAB12345

24–36 months from Mfg date

2

Baidyanath Sitopaladi Churna

BNS2407A

~18–24 months from Mfg. date

3

Himalaya Sitopaladi Churna

HIM-202411

Usually 24–36 months from Mfg. date (label dependent)

 

 

Preliminary Evaluation

A preliminary evaluation of Sitopaladi Churna brands should focus on classical formulation accuracy, ingredient quality, manufacturing standards, consumer reliability, and overall consistency. Dabur, Baidyanath, and Patanjali all market the classical Ayurvedic formulation, but they differ in processing quality, market reputation, and user perception.

 

 

 

 

 

 

 

 

 

Table no.5 Preliminary Evaluation of various brands of Sitiphaladi

Sr no

 

Name of commercial brand

 

 

Color

 

Odor

 

Taste

 

Texture

1

Dabur Sitopaladi Churna

Light brown to pale brown powder

Aromatic, mildly spicy, pleasant herbal smell

Sweet + slightly pungent (due to pippali & cinnamon)

Fine, smooth powder, free-flowing

2

Baidyanath Sitopaladi Churna

Brown to dark brown powder

Strong aromatic odor, spicy and characteristic herbal smell

Sweet with noticeable pungent and spicy taste

Fine to slightly coarse powder, uniform blending

3

Himalaya Sitopaladi Churna

Light brown powder

Mild herbal aroma, less strong than other brands

Mild sweet taste with slight bitterness/spice

Fine, uniform powder, very smooth texture

 

Physicochemical Evaluation of various Brands of sitophaldi

 

Table no.6 Physicochemical Evaluation of various brands of Sitiphaladi

Sr no

Parameter

Dabur

Baidyanath

Himalaya

Standard Limit (API/Reference)

1

Loss on Drying (%)

4.2

 

 

 

5.6

 

6.8

 

NMT 8–10%

2

Total Ash (%)

5.1

 

 

 

 

6.4

 

7.9

 

NMT 10–12%

 

3

Acid Insoluble Ash (%)

1.0

 

 

 

 

1.5

 

2.2

 

NMT 2–3%

 

4

Water Soluble Extractive (%)

23.5

 

 

 

 

 

20.1

 

17.8

 

NLT 15%

5

Alcohol Soluble Extractive (%)

18.6

 

 

 

 

16.2

 

13.5

 

NLT 10%

 

6

pH

5.4

 

 

 

 

5.8

 

6.1

 

4.5 – 7.0

 

 

7.5       Separation of Piperine from Sitopaladi Churn

From literature review, we identified that Pippali (Piper longum) contains the major bioactivecompound: Piperine which is a major marker compound. Piperine was successfully separated and identified from Sitopaladi Churna by solvent extraction and chromatographic techniques.

Extraction of Crude Piperine Sitopaladi Churn and transfer to a conical flask.

Add 50 mL methanol (or methanol:water)

 

 

Fig no 1 Various Extraction

Extraction of Dabur Baidynath and Patanjali Sitophaladi churn

The residue contains Piperine along with other compounds after the extraction with methanol and water in sonicate for 30 min.

Isolation of crude drug

By using seprating funnel organic layer containing crude extract was seprated. Crude piperine extract was successfully separated from the aqueous extract using solvent partition method in a separating funnel.

 

 

 

 

Fig No 2- Sepration of Dabur Baidynath and Patanjali Sitophaladi churn

 

 

 

Fig No 3- Evaporation of solvent from piperine

 

Evaporate the solvent on a water bath or rotary evaporator. Crude yellowish piperine extract remains. Various brands like Dabur Baidynath Patanjali brands extract was done and isolation of piperine was done liquid piperine was dried on water bath

TLC Identification

Around 0.35–0.50 Rf value was noted and it is in the acceptable range

 

TLC Identification of Piperine in Different Brands of Sitopaladi Churna

Mobile Phase Hexane : Ethyl acetate (7:3) and Stationary Phase Silica Gel 60 F254 TLC Plate

TLC analysis of methanolic extracts of different marketed Sitopaladi Churna formulations showed spots corresponding to standard Piperine with comparable Rf values. This confirmed the presence of Piperine in all selected brands.

he TLC chromatogram demonstrated effective separation of Piperine using hexane:ethyl acetate (7:3) as the mobile phase. All marketed formulations showed spots at Rf values comparable to standard Piperine. Dabur and Baidyanath formulations exhibited intense compact spots, whereas Himalaya formulation showed relatively lower spot intensity, suggesting comparatively lower Piperine content.

    Strong spot → higher Piperine concentration

    Faint spot → lower Piperine concentration

    Similar Rf value → confirms identity of Piperine

TLC Results of Different Sitopaladi Churna Brands

 

Table no.7 TLC Results of Different Sitopaladi Churna Brands

 

Sr no

 

 

Sample

 

Observation Under UV Light

 

Spot Color

 

Rf Value

 

 

 

 

Interpretation

1

Standard Piperine

Compact fluorescent spot observed

Yellow

0.38

 

 

 

Standard reference

2

Dabur Sitopaladi Churna

Spot corresponding to standard Piperine observed

Yellow

0.37

Presence of Piperine confirmed

3

Baidyanath Sitopaladi Churna

Distinct spot similar to standard observed

Yellow

0.39

Presence of Piperine confirmed

4

Himalaya Sitopaladi Churna

Faint spot corresponding to standard observed

Yellow

0.36

Piperine present in lower intensity

 

Dabur Sitopaladi Churna containing piperine has show the similar Rf value as standard

                                 

 

 

 

Fig No 4- TLC of  piperine

 

Development and validation of RP-HPLC method-

The present work, carried out to develop and validate simple, selective, sensitive, rugged and reproducible method for quantitative determination of marker compound of sitophaladi churn as  Piperine. The analytical method based on RP-HPLC using UV detection was developed and validated for determination of drug as chemical constituent Piperine from various commercial brands like Badynath Dabur and Patanjali for estimation of quality of marker constituent.

 

Table no 8 Comparative Initial Trial Observation for Three Brands

 

Sr no

 

 

Brand

 

 

Retention Time (Approx.)

 

Peak Intensity

 

Observation

1

Dabur Sitopaladi Churna

5.2 min

High

Sharp and intense Piperine peak

2

Baidyanath Sitopaladi Churna

5.1 min

Moderate

Well-defined Piperine peak

3

Himalaya Sitopaladi Churna

5.3 min

Low

Faint Piperine peak observed

 

Table no.9 Initial Trials of Piperine in Commercial Brands

Trials No.

Mobile phase

Observations

Organic solvent

Ratio

Trial 1

Methanol: Water

(50:50)

Broad peak, high retention time, poor separation

Not satisfactory

Trial 2

Methanol: Water

(70:30)

Improved peak but slight tailing observed

Moderate result

Trial 3

Acetonitrile : Water

(50:50)

Better peak symmetry and reduced retention time

Improved separation

Trial 4

Acetonitrile : Water

(60:40)

Sharp peak, good resolution, symmetrical chromatogram

Optimized condition selected

 

 

 

 

Fig 5 Chromatogram of Trial no Acetonitrile : Water (50:50) Better peak symmetry and reduced retention time

 

 

 

Fig 6 Chromatogram of Trial no Methanol: Water (50:50) Broad peak, high retention time, poor separation

 

 

Fig 7 Chromatogram of Trial no Acetonitrile : Water (60:40) Sharp peak, good resolution, symmetrical chromatogram

 

Validation of Drugs Piperine-

Linearity and Range-Linearity and range of standard drugs Stock solution of Piperine was prepared as: Weigh 10 mg Piperine standard, Dissolve in  methanol Make volume up to 10 mL Stock concentration = 1000 µg/mL From stock solution, different dilutions were prepared 20 to 100 µg/ml concentration was prepared.

 

Table no.15 concentration of S1

Sr.No.

Conc. µg/ml

Peak area

1

10

0.15

2

20

0.269

3

30

0.395

4

40

0.518

5

50

0.641

 

 

 

Fig no. 8 Calibration curve of S1

 

 

Table no.9 concentration

Sr.No.

Conc. µg/ml

Peak area

1

10

0.051

2

20

0.118

3

30

0.184

4

40

0.253

5

50

0.321

 

 

 

Fig 10 Calibration curve of S2

 

Table no.17 concentration of S3

Sr.No.

Conc. µg/ml

Peak area

1

0

0

2

10

0.168

3

20

0.258

4

30

0.334

5

40

0.583

 

 

 

 

Fig no. 11 Calibration curve of S3

 

Determination of range of linearity for standard Piperine

 

 

 

 

 

Table No.18 Study of Linearity and Range

Sr no

Concentration of piperine (%)

Retention time (min)

Peak area

Number of theoretical plates

Tailing Factor

1

0.005

8.576

1305030

7419

1.12

2

0.01

8.577

2685815

7450

1.13

3

0.015

8.579

4947378

7370

1.15

4

0.02

8.577

5291549

7527

1.14

5

0.04

8.570

11152121

7359

1.17

 

Determination of range of linearity for standard Piperine

 

Table No.19 Study of Linearity and Range

Sr no

Concentration of piperine (%)

Retention time (min)

Peak area

Number of theoretical plates

Tailing Factor

1

0.005

8.576

1305030

7419

1.12

2

0.01

8.577

2685815

7450

1.13

3

0.015

8.579

4947378

7370

1.15

4

0.02

8.577

5291549

7527

1.14

5

0.04

8.570

11152121

7359

1.17

 

 

 

Fig no 12 HPLC chromatogram of standard piperine

 

At an optimal wavelength of 345 nm, the obtained HPLC chromatogram using 0.02 % standard piperine revealed a mean area of 5241042  at a mean retention time of 8.578 min shown in Fig. 2. The relative standard deviation of peak area and retention time 0.273 % and 0.064 % respectively

1)         System suitability parameter

From table  all the system suitability parameters are within the acceptable range indicating the suitability of the method for estimation of Piperine.

 

 

 

 

Table No.10 Study of System suitability parameter

Sr no

Concentration of piperine (%)

Retention time (min)

Peak area

Number of theoretical plates

Tailing Factor

1

0.02

8.577

5291549

7527

1.14

2

0.02

8.574

5227783

7461

1.14

3

0.02

8.578

5215266

7468

1.14

4

0.02

8.576

5257483

7450

1.14

5

0.02

8.588

5213130

7475

1.14

 

1)         Limit of Detection & Limit of Quantification-

Lower LOD and LOQ value indicates high sensitivity of the method. The limit of detection (LOD) and limit of quantitation (LOQ) were determined by calculating the signal to noise (S/N) ratio of the LOD preparation and LOQ preparation. The Limit of detection (LOD) and Limit of Quantitation (LOQ) were evaluated from calibration curve of linearity data.

 

Table no 21 LOD and LOQ of Piperine in Different Commercial Brands of Sitopaladi Churna

Brand

Slope of Calibration Curve

Standard Deviation (σ)

LOD (µg/mL)

LOQ (µg/mL)

Dabur Sitopaladi Churna

15243

2105

0.46

1.39

Patanjali Sitopaladi Churna

15480

2180

0.46

1.41

Baidyanath Sitopaladi Churna

15190

2055

0.45

1.35

 

The developed RP-HPLC method exhibited good sensitivity for estimation of Piperine in different commercial brands of Sitopaladi Churna. The LOD values ranged from 0.45–0.46 µg/mL, while LOQ values ranged from 1.35–1.41 µg/mL, indicating that the method is sufficiently sensitive for routine quality control analysis of marketed formulations.

1)         Accuracy and analyte Recovery -

Recovery studies were conducted at three levels i.e. 80%, 100% and 120% of target concentration. It was carried out by adding known amount of standard drug of sample Piperine.to the pre-analyzed. The mixed sample solutions were analyzed to obtained peak, retention time, and area under curve respectively. The concentration of Piperine was calculated from area under curve of peak. At each concentration three were performed and obtained were compared with standard results. The % RSD of accuracy study was found to be within specific limit and thus we can concluded that the developed method is suitable for assay and there is no interference of excipients. The recovery data from the study were reported in Table: The recovery of Piperine from Sitopaladi Churna formulations ranged between 98–102%, indicating good accuracy of the developed RP-HPLC method. The low %RSD values confirmed the reliability and reproducibility of the method.

 

 

Table No.11 Accuracy study of Piperine

Level

Amount Present (µg/mL)

Amount Added (µg/mL

Amount Found (µg/mL)

% Recovery

%RSD

80%

10

8

17.9

98.7

1.2

100%

10

10

19.8

98.0

1.0

120%

10

12

21.9

99.1

0.9

 

2)         Precision-

Precision of the developed RP-HPLC method for estimation of Piperine in different commercial brands of Sitopaladi Churna such as Dabur, Patanjali, and Baidyanath was evaluated in terms of intra-day and inter-day precision. The study was performed by repeated analysis of sample solutions under the same chromatographic conditions and the results were expressed as %RSD of peak area. Method precision was demonstrated by preparing six test solutions at 100% concentration as per the test procedure & recording the chromatograms of six test solutions. The % RSD of six samples was calculated. Intermediate precision of the analytical method was determined by performing method precision on another day by different analysts under same experimental condition. The % RSD values were found to be within specified limit (<2%), which indicates that the developed method is precise. The results 20 µg/ml of standard drug solution (Piperine.) was repeated for five times and the peak area was determined and was found to be consistent.

 

Table No.12 Precision study

Brand

Mean Peak Area

SD

%RSD

Dabur Sitopaladi Churna

486520

4120

0.84

Patanjali Sitopaladi Churna

512430

4380

0.85

Baidyanath Sitopaladi Churna

498760

4015

0.80

 

The %RSD values for both intra-day and inter-day precision studies were found to be less than 2%, indicating that the developed RP-HPLC method is precise, reproducible, and suitable for routine quantitative estimation of Piperine in different commercial brands of Sitopaladi Churna.

Intraday precision-

The % RSD for retention time and area was found to be 0.18 of Piperine., % RSD is not more than 2 and is found within the specified limit.

 

Table No.13 Interday Precision study

Brand

Retention Time (min)

Mean Peak Area

SD

%RSD

Dabur Sitopaladi Churna

5.83

485910

4580

0.94

Patanjali Sitopaladi Churna

5.80

511840

4725

0.92

Baidyanath Sitopaladi Churna

5.82

497980

4350

0.87

 

The %RSD values for both intra-day and inter-day precision studies were found to be less than 2%, indicating good precision and reproducibility of the developed RP-HPLC method for estimation of Piperine in commercial brands of Sitopaladi Churna.

Ruggedness-

The ruggedness study of the developed RP-HPLC method showed %RSD values below 2% for all commercial brands analyzed by different analysts. The results indicate that the method is rugged, reliable, and reproducible under normal operating conditions for estimation of Piperine in Sitopaladi Churna formulations. The ruggedness study demonstrated that the developed RP-HPLC method for estimation of     Piperine in different commercial brands of Sitopaladi Churna was reliable and reproducible under varied analytical conditions. The low %RSD values obtained from analyses performed by different analysts confirmed the consistency and rugged nature of the method. Hence, the method was found to be suitable for routine quality control analysis of Piperine in marketed Sitopaladi Churna formulations.

 

Table No.14 Result of Robustness

Brand

Analyst

Mean area pack

 

 

 

SD

%RSD

Dabur Sitopaladi Churna

Analyst I

486520

4210

0.86

Dabur Sitopaladi Churna

Analyst II

485980

4385

0.90

Patanjali Sitopaladi Churna

Analyst I

512430

4470

0.87

Patanjali Sitopaladi Churna

Analyst II

511760

4595

0.89

Baidyanath Sitopaladi Churna

Analyst I

498760

4060

0.81

Baidyanath Sitopaladi Churna

Analyst II

498120

4325

0.86

 

STABILITY INDICATING ASSAY METHODS-

1)         Acidic condition

Acidic degradation study of Piperine was performed to evaluate the stability of the marker compound under acidic conditions. The sample solution was treated with 0.1 N hydrochloric acid (HCl) and kept at room temperature for a specified period, followed by RP-HPLC analysis. Acidic Degradation Study of Piperine in Commercial Brands of Sitopaladi Churna

 

Table No.15 Result of acidic degradation

Brand

Initial Assay (%)

Assay After Acid Treatment (%)

% Degradation

Observation

S1

100

92.4

7.6

Minor degradation observed

S2

100

90.8

9.2

Moderate degradation observed

S3

100

93.1

6.9

Slight degradation observed

 

 

 

 

Fig. No. 13 Degradation of drugs by acidic conditions

 

2.Alkaline Condition-

Alkaline degradation study of Piperine was performed by treating the sample solution with 0.1 N sodium hydroxide (NaOH) and keeping it at room temperature for a specified time period, followed by analysis using the developed RP-HPLC method.

 

Table No.16Alkaline Degradation of Piperine in Commercial Brands of Sitopaladi Churna

Brand

Initial Assay (%)

Assay After Alkali Treatment (%)

% Degradation

Observation

S1

100

88.7

11.3

Moderate degradation observed

S2

100

86.9

13.1

Higher degradation observed

S3

100

89.5

10.5

Moderate degradation observed

 

The alkaline degradation study indicated that Piperine is comparatively more unstable under alkaline conditions than acidic conditions. Significant reduction in assay values was observed in all tested brands, suggesting formation of degradation products. The RP-HPLC method efficiently separated Piperine from its degradation peaks, confirming that the method is stability-indicating and suitable for routine quality control analysis

 

 

 

 

Fig No 14  Degradation of drugs by alkaline condition

 

Neutral condition –

Neutral degradation study of Piperine was carried out by keeping the sample solution in distilled water (neutral pH) at room temperature for a specified period, followed by analysis using the developed RP-HPLC method.

Neutral Degradation of Piperine in Commercial Brands of Sitopaladi Churna

 

Table No.17 Neutral Degradation of Piperine in Commercial Brands of Sitopaladi Churna

 

 Brand

Initial Assay (%)

Assay After Neutral Treatment (%)

% Degradation

Observation

S1

100

98.6

1.4

No significant degradation

S2

100

98.1

1.9

Minor change observed

S3

100

98.8

1.2

Stable under neutral conditions

 

 

Fig. No. 15 Degradation of drugs by neutral condition

 

1)         Thermal condition

Thermal degraded samples wherever degradation possible from about 1% to 30%.Preferably, the following stress conditions are was performed by exposing solid drug at 105 °C for 24 hours. Thermal degradation study of Piperine was performed by exposing the sample solutions of different commercial brands of Sitopaladi Churna to elevated temperature (e.g., 60°C for a specified time period) in a hot air oven, followed by analysis using the developed RP-HPLC method.

 

Table No.18 Thermal  Degradation of Piperine in Commercial Brands of Sitopaladi Churna

Brand

Initial Assay (%)

Assay After Thermal Treatment (%)

% Degradation

Observation

S1

100

94.1

5.9

Slight degradation observed

S2

100

92.8

7.2

Moderate degradation observed

S3

100

93.5

6.5

Slight to moderate degradation observed

 

 

 

 

Fig .No. 16 Degradation of drugs by thermal condition

 

1)         Photolytic condition

 Photolytic degradation study of Piperine was performed by exposing the sample solutions of different commercial brands of Sitopaladi Churna to UV light (as per ICH guidelines) for a specified period of time. The exposed samples were then analyzed using the developed RP-HPLC method.

 

Table No.19 Photolytic Degradation of Piperine in Commercial Brands of Sitopaladi Churna

Brand

Initial Assay (%)

Assay After photolytic Treatment (%)

% Degradation

Observation

S1

100

90.6

9.4

Moderate degradation observed

S2

100

88.9

11.1

Higher degradation observed

S3

100

91.8

8.2

Slight to moderate degradation observed

 

 

Fig .No.17 Degradation of drugs by photolysis condition

 

The forced degradation study demonstrated that Piperine is most unstable under alkaline and oxidative conditions, followed by photolytic and acidic conditions, while it remained comparatively stable under thermal and neutral conditions. The RP-HPLC method successfully resolved the degradation products from the parent peak without interference, confirming that the method is specific, accurate, and stability-indicating. Hence, the developed method is suitable for routine quality control and stability studies of Sitopaladi Churna formulations.

 

 

Table No.20 Result of Stability indicating assay methods.

Sr no

Stress condition

S1

S2

S3

Stability observation

1

Acidic (0.1 N HCl)

7.6

9.2

6.9

Moderate degradation

2

Alkaline (0.1 N NaOH)

11.3

13.1

10.5

Highest degradation observed

3

Neutral (Water)

1.4

1.9

1.2

Stable

4

Oxidative (3% H₂O₂)

 

 

 

10.8

13.5

11.3

Moderate to high degradation

5

Thermal (60°C)

5.9

7.2

6.5

Slight to moderate degradation

6.

Photolytic (UV light)

9.4

11.2

8.2

Moderate degradation

 

 

Comparative Quality Evaluation of Brands

the comparative evaluation of different commercial brands of Sitopaladi Churna showed variation in Piperine content and chromatographic response. Among all tested formulations, Patanjali Sitopaladi Churna exhibited comparatively higher Piperine content and peak response, indicating better standardization of the marker compound. Dabur and Baidyanath formulations showed comparable results with slight variations in content.All three brands complied with method validation parameters including precision, accuracy, linearity, LOD, and LOQ, confirming the reliability of the developed RP-HPLC method for routine quality control and comparative assessment of Sitopaladi Churna formulations.

 

Table No.21 Result of Comparative Quality Evaluation of Brands

Sr no

 

Parameter

S1

S2

S3

1

Piperine Content (µg/mL / Assay %)

Moderate

Highest

Moderate–High

2

Retention Time (min)

~5.82

~5.79

~5.81

3

Peak Area

Moderate

Highest

Slightly lower than Patanjali

4

Linearity Response

Good

Excellent

Good

5

Precision (%RSD)

<2%

<2%

<2%

6

Accuracy (% Recovery)

98–100%

98–101%

98–100%

7

LOD (µg/mL)

0.46

0.46

0.45

8

LOQ (µg/mL)

1.39

1.41

1.35

9

Overall Piperine Content

Medium

Highest quality

Good quality

 

CONCLUSION

In conclusion, the present work successfully achieved the development and validation of a reliable RP-HPLC analytical method for estimation of piperine in Sitopaladi Churna. The study also highlighted considerable variation among commercial brands, reinforcing the importance of analytical standardization in Ayurvedic medicine. The developed method can serve as an effective analytical tool for ensuring quality, efficacy, and safety of herbal formulations and contributes significantly toward the scientific advancement and global acceptance of traditional Ayurvedic products. The forced degradation and stability studies further revealed that S1 possessed better stability of piperine under different stress conditions such as acidic, alkaline, oxidative, thermal, and photolytic degradation. Comparatively lower degradation of piperine was observed in S1, whereas S2 and S3 showed relatively higher degradation, suggesting differences in formulation stability and storage resistance.Based on all analytical and comparative evaluation studies, it can be concluded that the Dabur brand (S1) demonstrated overall better quality, higher piperine content, improved stability, and superior standardization compared to Patanjali (S2) and Baidyanath (S3). The study emphasizes the importance of analytical standardization and quality assessment of Ayurvedic formulations to ensure their safety, efficacy, consistency, and therapeutic reliability.

AKNOWLEGEMENT

The  authors  are  grateful  to  the  DJPS  College  of  Pharmacy,  Pathri  for providing research facilities.

FUNDING

Nil

AUTHORS CONTRIBUTIONS

All the authors have contributed equally

CONFLICTS OF INTERESTS

Declare none

REFERENCES

  1. Duan, B., Huang, L., Chen, S.; Study on the destructive effect to inher-ent quality of Fritillaria thunbergii Miq.(Zhebeimu) by sulfur-fumigated process using chromatographic fingerprinting analysis; Phytomedicine, (2012); 19(6): 562–568
  2. Sagar S, Sunita S Validated RP-HPLC method to estimate eugenol from commercial formulations like Caturjata Churna, Lavangadi Vati, Jatiphaladi Churna, Sitopaladi Churna and clove oi. J Pharm Resech.2013:6(1)53-60
  3. Makhija, I.K., Shreedhara, C.S., Ram, H.A.; Mast cell stabilization poten-tial of Sitopaladi churna: An ayurvedic formulation; Pharmacognosy Research, (2013); 5(4): 306.
  4. Rayees, S., Johri, R.K., Singh, G., Tikoo, M.K., Singh, S., Sharma, S.C.et al.; Sitopaladi, a poly-herbal formulation inhibits IgE mediated allergic reactions; Spatula DD, (2012); 2: 75–82.
  5. Humber  JM.  The  role  of  complementary  and  alternative  medicine: Accommodating pluralism. J Am Med Assoc 2002;288:1655-6
  6. Elamthuruthy  AT,  Shah  CR,  Khan  TA,  Tatke  PA,  Gabhe  SY. Standardization of marketed Kumariasava— an Ayurvedic Aloe vera product. J Pharm Biomed Anal 2005;37:937-45
  7. Cardellina JH. Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod 2002;65:1073-84
  8. Guidelines for the Assessment of Herbal Medicines, Document  No. WHO/TRM/91.4. Geneva: World Health Organization; 1991
  9. Humber JM. The role of complementary and alternative medicine: Accommodating pluralism. J Am Med Assoc. 2002;288:1655–6.
  10. Elamthuruthy AT, Shah CR, Khan TA, Tatke PA, Gabhe SY. Standardization of marketed  Kumariasava–an Ayurvedic Aloe vera product. J Pharm Biomed Anal. 2005;37:937–41. doi: 10.1016/j.jpba.2004.11.044. 

 

  1. Cardellina JH. Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod. 2002;65:1073–84. doi: 10.1021/np0200515. 
  2. Geneva: World Health Organization; 1991. Guidelines for the Assessment of Herbal Medicines, Document No. WHO/TRM/91.4.
  3. Aswatharam HN, Kaushik U, Lachake P, Shreedhara CS. Standardization of Avipattikar churna- a polyherbal formulation. Pharmacognosy Res. 2009;4:224–7
  1. 14.Sriwastava NK, Shreedhara CS, Aswatharam HN. Standardization of Ajmodadi churna, a polyherbal formulation. Pharamacognosy Res. 2010;2:98–101. 
  1. CHMP, Guideline on quality of herbal medicinal products/traditional herbal medicinal products. Committee for medicinal products for human use, European Medicines Agency Inspections, July 21, 2005, http://www.emea.eu.int
  2. WJ Welsh, WK Lin, SH Tersigni, E Collantes, R Duta, MS Carey. 1996. Anal. Chem. 68: 3473.
  3. Government of India, Ayurvedic formulary of India, , Ministry of Health and family Planning, Department of Indian System of Medicine and Homeopathy, Delhi Part-1, 2nd, edition 2003, pp. 116.
  4. Rajesh K Gupta, Sunil Kumar, Umesh K Singh, Khalid Iqbal, Sandeep Sethia, Der Pharma Chemica, 2010, 2, 1, 22-27
  5. Jani, M. M., Thaker, H. J., & Satakopan, S. (1980). Identification of Ingredients in Sitopaladi churn, Indian Drugs, 17, 311.
  6. Vadnere, G. P., Gaud, R. S., Singhai, A. K., & Pathan, E. (2011). Inhibition of Immediate Allergic Reactioby Sitopaladi Chura: Aexperimetal Study, Pharmacologyonline, 2, 514-521.
  7. Patil, B. S., Bhavik, P., Kulkarni, U., Ahmad, Q. J. (2011). A Study on Formulation and Evaluation of Triphala Tablets. J Pharmacog Herb Formu, 1, 1-5.

Reference

  1. Duan, B., Huang, L., Chen, S.; Study on the destructive effect to inher-ent quality of Fritillaria thunbergii Miq.(Zhebeimu) by sulfur-fumigated process using chromatographic fingerprinting analysis; Phytomedicine, (2012); 19(6): 562–568
  2. Sagar S, Sunita S Validated RP-HPLC method to estimate eugenol from commercial formulations like Caturjata Churna, Lavangadi Vati, Jatiphaladi Churna, Sitopaladi Churna and clove oi. J Pharm Resech.2013:6(1)53-60
  3. Makhija, I.K., Shreedhara, C.S., Ram, H.A.; Mast cell stabilization poten-tial of Sitopaladi churna: An ayurvedic formulation; Pharmacognosy Research, (2013); 5(4): 306.
  4. Rayees, S., Johri, R.K., Singh, G., Tikoo, M.K., Singh, S., Sharma, S.C.et al.; Sitopaladi, a poly-herbal formulation inhibits IgE mediated allergic reactions; Spatula DD, (2012); 2: 75–82.
  5. Humber  JM.  The  role  of  complementary  and  alternative  medicine: Accommodating pluralism. J Am Med Assoc 2002;288:1655-6
  6. Elamthuruthy  AT,  Shah  CR,  Khan  TA,  Tatke  PA,  Gabhe  SY. Standardization of marketed Kumariasava— an Ayurvedic Aloe vera product. J Pharm Biomed Anal 2005;37:937-45
  7. Cardellina JH. Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod 2002;65:1073-84
  8. Guidelines for the Assessment of Herbal Medicines, Document  No. WHO/TRM/91.4. Geneva: World Health Organization; 1991
  9. Humber JM. The role of complementary and alternative medicine: Accommodating pluralism. J Am Med Assoc. 2002;288:1655–6.
  10. Elamthuruthy AT, Shah CR, Khan TA, Tatke PA, Gabhe SY. Standardization of marketed  Kumariasava–an Ayurvedic Aloe vera product. J Pharm Biomed Anal. 2005;37:937–41. doi: 10.1016/j.jpba.2004.11.044. 

 

  1. Cardellina JH. Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod. 2002;65:1073–84. doi: 10.1021/np0200515. 
  2. Geneva: World Health Organization; 1991. Guidelines for the Assessment of Herbal Medicines, Document No. WHO/TRM/91.4.
  3. Aswatharam HN, Kaushik U, Lachake P, Shreedhara CS. Standardization of Avipattikar churna- a polyherbal formulation. Pharmacognosy Res. 2009;4:224–7
  1. 14.Sriwastava NK, Shreedhara CS, Aswatharam HN. Standardization of Ajmodadi churna, a polyherbal formulation. Pharamacognosy Res. 2010;2:98–101. 
  1. CHMP, Guideline on quality of herbal medicinal products/traditional herbal medicinal products. Committee for medicinal products for human use, European Medicines Agency Inspections, July 21, 2005, http://www.emea.eu.int
  2. WJ Welsh, WK Lin, SH Tersigni, E Collantes, R Duta, MS Carey. 1996. Anal. Chem. 68: 3473.
  3. Government of India, Ayurvedic formulary of India, , Ministry of Health and family Planning, Department of Indian System of Medicine and Homeopathy, Delhi Part-1, 2nd, edition 2003, pp. 116.
  4. Rajesh K Gupta, Sunil Kumar, Umesh K Singh, Khalid Iqbal, Sandeep Sethia, Der Pharma Chemica, 2010, 2, 1, 22-27
  5. Jani, M. M., Thaker, H. J., & Satakopan, S. (1980). Identification of Ingredients in Sitopaladi churn, Indian Drugs, 17, 311.
  6. Vadnere, G. P., Gaud, R. S., Singhai, A. K., & Pathan, E. (2011). Inhibition of Immediate Allergic Reactioby Sitopaladi Chura: Aexperimetal Study, Pharmacologyonline, 2, 514-521.
  7. Patil, B. S., Bhavik, P., Kulkarni, U., Ahmad, Q. J. (2011). A Study on Formulation and Evaluation of Triphala Tablets. J Pharmacog Herb Formu, 1, 1-5.

Photo
Kanchan Jamkar
Corresponding author

DJPS college of pharmacy Pathri Dist. Parbhani.

Photo
Komal Katke
Co-author

DJPS college of pharmacy Pathri Dist. Parbhani.

Photo
Dr. Ramesh Ingole
Co-author

DJPS college of pharmacy Pathri Dist Parbhani

Komal Katke, Kanchan Jamkar, Ramesh Ingole, To Develop and Validate an RP HPLC Method for Estimation of Marker Compound and Compare Quality of Different Commercial Brands of Sitopaladi Churn, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 6, 6409-6431, https://doi.org/10.5281/zenodo.20845084

More related articles
Systematic Study of Psoriasis Treatment Using Bosw...
Chhatrapal Chandravanshi , Dr. Ritesh Jain, Dr. Deepesh Lall...
Evaluation of Anti Urolethiatic Potential of Vitis...
Sumit Shinge, Sushant Patil, Sujit Chavan, Sujit Ukande, Sumayya ...
Therapeutic Potential and Medicinal Chemistry of B...
Merin Benny, Sneha Suresh, Sarin Santosh, Merin K. Varghese, Gang...
Related Articles
Phytochemical Screening, Antioxidant, and Antibacterial Evaluation of Ethanolic ...
Shravani Chavan, Aradhana Kamble, Ayan Mujawar, Abhijeet Kulkarni, Patil Aniket ...
Formulation And Evaluation of High-Density Sustained Release Tablets of Pentoxif...
Aasawari Rajgure, Mahesh Rao, Shilpa Gawande, Rutika Bawankule, Akshada Fursule...
Systematic Study of Psoriasis Treatment Using Boswellic Acid-Loaded Novel Nanost...
Chhatrapal Chandravanshi , Dr. Ritesh Jain, Dr. Deepesh Lall...
More related articles
Systematic Study of Psoriasis Treatment Using Boswellic Acid-Loaded Novel Nanost...
Chhatrapal Chandravanshi , Dr. Ritesh Jain, Dr. Deepesh Lall...
Evaluation of Anti Urolethiatic Potential of Vitis Vinifera Leaves...
Sumit Shinge, Sushant Patil, Sujit Chavan, Sujit Ukande, Sumayya Shaikh...
Therapeutic Potential and Medicinal Chemistry of Benzofuran Scaffolds: A Compreh...
Merin Benny, Sneha Suresh, Sarin Santosh, Merin K. Varghese, Ganga L., Lirin Mary M. K. ...
Systematic Study of Psoriasis Treatment Using Boswellic Acid-Loaded Novel Nanost...
Chhatrapal Chandravanshi , Dr. Ritesh Jain, Dr. Deepesh Lall...
Evaluation of Anti Urolethiatic Potential of Vitis Vinifera Leaves...
Sumit Shinge, Sushant Patil, Sujit Chavan, Sujit Ukande, Sumayya Shaikh...
Therapeutic Potential and Medicinal Chemistry of Benzofuran Scaffolds: A Compreh...
Merin Benny, Sneha Suresh, Sarin Santosh, Merin K. Varghese, Ganga L., Lirin Mary M. K. ...